Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 Million – Forbes

1. Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 Million  Forbes
2. Sun Pharma to acquire Checkpoint Therapeutics for $355 million in cash and milestone payments  CNBCTV18
3. Sun Pharma to acquire US oncology compony for over Rs 3,000 crore  The Times of India
4. Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million or over Rs 3,000 crore  Moneycontrol
5. Sun Pharmaceuticals to acquire Checkpoint Therapeutics for $355 mn  The Economic Times

 Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 Million  ForbesSun Pharma to acquire Checkpoint Therapeutics for $355 million in cash and milestone payments  CNBCTV18Sun Pharma to acquire US oncology compony for over Rs 3,000 crore  The Times of IndiaSun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million or over Rs 3,000 crore  MoneycontrolSun Pharmaceuticals to acquire Checkpoint Therapeutics for $355 mn  The Economic Times  Top stories – Google News